Table 3. Illumina HT-12v4 Expression BeadChip gene expression array data for genes followed up by bisulfite pyrosequencing.
Gene | Array probe | RNA expression (Fluorescent Units) | P-value | |
Control | EOPET | |||
NR3C1 | ILMN_2389347 | 59.4±16.3 | 57.8±12.2 | NS |
CRH | ILMN_1668035 | 64.22±20.6 | 1431±1124 | <0.01 |
CRHBP | ILMN_1761312 | 153.9±137.6 | 90.7±90.5 | NS |
CYP11A1 | ILMN_1768820 | 442.8±277.2 | 1750±1377 | <0.01 |
HSD3B1 | ILMN_1780693 | 238.4±120.2 | 1193±857 | <0.01 |
TEAD3 | ILMN_1814002 | 118.9±44.9 | 119.9±38.8 | NS |
CYP19 | ILMN_2387860 | 112.0±54.6 | 671.4±579.8 | <0.01 |
HSD11B2 | ILMN_1813350 | 37.4±21.5 | 148.6±294.2 | NS |
The Illumina probe identifier, mean ± SD expression values and the associated P-value is given for each gene for a subset of control (n = 8) and early onset pre-eclampsia (EOPET; n = 8) placental samples. NR3C1: nuclear receptor subfamily 3, group C, member 1, CRHBP: corticotropin releasing hormone (CRH) binding protein: HSD3B1∶3β-hydroxy-delta-5-steroid dehydrogenase type 1, TEAD3: TEA domain family member 3, HSD11B2∶11β-hydroxysteroid dehydrogenase type 2.